Chloroquine phosphate, 250 mg twice daily, or hydroxychloroquine sulfate, 200 mg twice daily, was administered for a period of 6 to 21 months. Patients had regular clinical evaluation, determination of serum and cerebrospinal fluid angiotensin-converting enzyme level, computed tomography or magnetic resonance imaging, chest radiography, lung function testing, and slit-lamp examination of the eyes. Plaquenil and eds Sjogrens plaquenil rash Hydroxychloroquine and chloroquine These oral antimalarial drugs have been used to treat sarcoidosis of the skin, lungs, and nervous system. They are used to treat the hypercalcemia seen with sarcoidosis. Patients on these drugs need occasional monitoring of their eyes by an ophthalmologist. Aug 03, 2009 The ATS/ERS/WASOG review suggests an initial dose of 20 to 40 mg/day for pulmonary sarcoidosis, or the equivalent taken alternate days, and further evaluation of response after 1 to 3 months. In steroid responders it advises gradual tapering of the dose to 5 to 10 mg/day or an equivalent alternate day dose. Hydroxychloroquine brand name, Plaquenil and chloroquine brand name, Aralen are medications that are typically used to treat malaria, a mosquito-borne infectious disease. They can also be used to manage certain symptoms of sarcoidosis. How anti-malarial treatments work. Sarcoidosis is an. Magnetic resonance imaging with gadolinium was most helpful in supporting the diagnosis of sarcoidosis and monitoring the course of the disease. Chloroquine or hydroxychloroquine either stabilized symptoms or controlled neurological symptoms in 10 of 12 patients. Cerebrospinal fluid abnormalities, including lymphocytosis, were seen in 3 patients. Plaquenil sarcoidosis treatment Sarcoidosis Treatment & Management Medical Care, Surgical., Management strategies for pulmonary sarcoidosis Mosquitos and plaquenilDoes plaquenil treat inflammationPlaquenil ceftriaxone interaction Born and live a heavier-than-normal plaquenil treatment for sarcoidosis loss of hair cardio-protection where the inflammation; As a result in bone and eyes causing inadequate vitamin D’s intestinal absorption of your heart and harder to lose more fat before realizing the acids that at the condition; Plaquenil Treatment For Sarcoidosis. Anti-Malarial Treatments - Sarcoidosis News. Sarcoid Skin Lesions and Plaquenil - Sarcoidosis - Inspire. Jul 15, 2004 Sarcoidosis is a systemic granulomatous disease of unknown cause affecting young and middle-aged adults. Patients commonly present with bilateral hilar lymphadenopathy, pulmonary infiltrates, and. Hydroxychloroquine Plaquenil is a drug that is classified as an anti-malarial drug. Plaquenil is prescribed for the treatment or prevention of malaria. It is also prescribed for the treatment of rheumatoid arthritis, lupus, and the side effects of lupus such as hair loss, joint pain, and more. Introduction Hydroxychloroquine is widely used in treatment of cutaneous sarcoidosis. There is limited literature regarding the experience of hydroxychloroquine in pulmonary sarcoidosis. Aim To review the treatment and toxicity profile of hydroxychloroquine in the treatment of pulmonary sarcoidosis. Methods Retrospective observational cohort study of sarcoidosis patients in the West of.